Telman Deborah H's Form 4 filing
Gilead Sciences, Inc. (GILD) · filed Nov 13, 2025
- Accession no.
- 0001860008-25-000009
- Filed
- Nov 13, 2025
- Trade date
- Nov 12, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $6.59M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Telman Deborah HCIK 0001860008 | Officer (EVP, Corporate Affairs & GC) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 12, 2025 | Common Stock | MOption exerciseAcquired | +17,181 | $75.12 | +$1,290,636.72 | 60,857 | Direct | |
| Nov 12, 2025 | Common Stock | SSaleDisposed | −17,181 | $124.00 | −$2,130,444 | 43,676 | Direct | |
| Nov 12, 2025 | Common Stock | MOption exerciseAcquired | +35,965 | $60.75 | +$2,184,873.75 | 79,641 | Direct | |
| Nov 12, 2025 | Common Stock | SSaleDisposed | −35,965 | $122.30F2 | −$4,398,519.5 | 43,676 | Direct | |
| Nov 12, 2025 | Common Stock | MOption exerciseAcquired | +500 | $60.75 | +$30,375 | 44,176 | Direct | |
| Nov 12, 2025 | Common Stock | SSaleDisposed | −500 | $122.90F3 | −$61,450 | 43,676 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 12, 2025 | Common Stock | MOption exerciseDisposed | −17,181 | $0.00 | $0 | 37,799 | Direct | |
| Nov 12, 2025 | Common Stock | MOption exerciseDisposed | −35,965 | $0.00 | $0 | 12,655 | Direct | |
| Nov 12, 2025 | Common Stock | MOption exerciseDisposed | −500 | $0.00 | $0 | 12,155 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Sales prices for the transactions reported here range from $121.87 to $122.83. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
Referenced by the price of 1 transaction in Table I.
- F3
Sales prices for the transactions reported here range from $122.88 to $122.92. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
Referenced by the price of 1 transaction in Table I.